Liver Quantification and Liver Fat
Wildman-Tobriner B, Middleton MM, Moylan CA, Rossi S, Flores O, Chang ZA, Abdelmalek MF, Sirlin CB, Bashir MR. Association between magnetic resonance imaging-proton density fat fraction and liver histology features in nonalcoholic fatty liver disease and non-alcoholic steatohepatitis. Gastroenterology. 2018 Nov; 155(5): 1428-1435.e2
Harrison SA, Rinella ME, Abdelmalek MF, Trotter JF, Paredes AH, Arnold HL, Kugelmas M, Bashir MR, Jaros MJ, Ling L, Rossi SJ, DePaoli AM, Loomba R. NGM282 for treatment of non-alcoholic steatohepatitis: A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet, 2018 Mar 24;391(10126):1174-1185.
Middleton MS, Heba ER, Hooker CA, Bashir MR, Fowler KJ, Sandrasegaran K, Brunt EM, Kleiner DE, Doo E, Van Natta ML, Tonascia JT, Lavine JE, Neuschwander-Tetri BA, Sanyal A, Loomba R, Sirlin CB; NASH Clinical Research Network. Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assisted steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology, 2017 Sep;153(3):753-761.
Bashir MR, Zhong X, Nickel MD, Fananapazir G, Kannengiesser SAR, Kiefer B, Dale BM. Quantification of hepatic steatosis with a multistep adaptive fitting MR imaging approach: prospective validation against MR spectroscopy. Am J Roentgenol. 2015 Feb;204(2):297-306.
Zhong X, Nickel MD, Kannengisser SA, Dale BM, Keifer B, Bashir MR. Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging. Magn Reson Med, 2014 Nov;72(5):1353-65.
Click here for Additional Publications for Liver Quantification and Liver Fat
Tang A, Bashir MR, Corwin MT, Cruite I, Dietrich CF, Do RKG, Ehman EC, Fowler KJ, Hussain HK, Jha RC, Karam AR, Mamidipalli A, Marks RM, Mitchell DG, Morgan TA, Ohliger MA, Shah A, Vu KN, Sirlin CB; LI-RADS Evidence Working Group. Evidence supporting LI- RADS major features for CT- and MR Imaging-based diagnosis of heptocellular carcinoma: A systematic review. Radiol, 2018 Jan;286(1):29-48.
Sofue K, Burke LM, Nilmini V, Alagiyawanna M, Muir AJ, Choudhury KR, Jaffe TA, Semelka RC, Bashir MR. Liver Imaging Reporting and Data System Category 4 Observations in MRI: Risk Factors Predicting Upgrade to Category 5. J Magn Reson Imaging, 2017 Sep;46(3):783- 792.
Bashir MR, Huang R, Mayes N, Marin D, Berg CL, Nelson RC, Jaffe TA. Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications, J Magn Reson Imaging, 2015 Aug;42(2):305-14.
Marks RM, Ryan A, Heba EH, Tang A, Wolfson TJ, Gamst AC, Sirlin CB, Bashir MR. Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. Am J Roentgenol, 2015 Mar;204(3):527-535.
Bashir MR, Gupta RT, Davenport MS, Allen BC, Jaffe TA, Ho LM, Boll DT, Merkle EM. Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis? J Magn Reson Imaging, 2013 Feb;37(2):398-406.
Click here for Additional Publications for Liver Cancer
McClellan TR, Motosugi U, Middleton MS, Allen BC, Jaffe TA, Miller CM, Reeder SB, Sirlin CB, Bashir MR. Intravenous gadoxetate disodium administration reduces breath-holding capacity in the hepatic arterial phase – A multi-center randomized placebo-controlled trial. Radiol, 2017 Feb;282(2):361-368.
Vasanawala S, Nguyen KL, Hope MD, Bridges MD, Hope TA, Reeder SB, Bashir MR. Safety and technique of ferumoxytol administration for MRI. Magn Reson Med, 2016 May;75(5):2107- 11.
Bashir MR, Bhatti L, Marin D, Nelson RC. Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging, 2015 Apr;41(4):884-98.
Pietryga JA, Burke LMB, Marin Daniele, Jaffe TA, Bashir MR. Respiratory motion artifact affecting hepatic arterial phase hepatic arterial phase imaging with gadoxetate disodium – Examination recovery using multi-arterial phase acquisition. Radiology, 2014 May;271(2):426- 34.
Bashir MR, Jaffe TA, Brennan TV, Patel UD, Ellis MJ. Renal transplant imaging using magnetic resonance angiography with a non-nephrotoxic contrast agent. Transplantation, 2013 Jul 15;96(1):91-6.
Click here for Additional Publications for Contrast Agents